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Objective
• To give a brief overview of NAS 
pathophysiology
• To understand evidence based approach to 
care for Substance Exposed Newborns 
(SENs)
• To understand parental role in care 
provision to SENs
Neonatal Abstinence Syndrome
• Complex disorder with a recognized 
constellation of behavioral and physiologic 
symptoms and signs following discontinuation 
of prolonged exposure to opiate agents or other 
substances
• Due to CNS hyper arousal during re-
adaptation to the absence of the drug of 
dependence
• Infants are born with physiological drug-
dependence and NOT drug- addicted
NAS : Incidence
• 2000 and 2009, the incidence of NAS among 
newborns increased from 1.20 to 3.39 per 1000 
hospital births per year
• Antepartum maternal opiate use also increased 
from 1.19 to 5.63 per 1000 hospital births per 
year 
• Mean hospital charges for discharges with NAS 
increased from $39,400 in 2000 to $53,400 in 
20091
1. Patrick et al.Neonatal abstinence syndrome and associated health care expenditures United States, 2000-2009. JAMA. 2012; 307: 1934-1940
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Slide courtesy NeoQIC: Neonatal Quality Improvement Collaborative of Massachusetts
Pre- conception
Prenatal
Postnatal
Post 
discharge
Healthy 
Maternal-
Infant 
Dyad
Pre-conception
• Current focus is on providing much needed prenatal care to 
pregnant women affected with substance use and 
improving pharmacological therapy for the infants with NAS
• Areas that need more focus and resources are programs 
geared towards pre-conception rehabilitation off drugs 
with potential for abuse and/or weaning off of MAT
• Greater awareness/education for women of child bearing 
age of the impact of prenatal exposure on their newborns 
not only due to NAS but potential long term neuro-
developmental and behavioral outcomes
Prenatal Management
• Rehabilitation through Medically Assisted Treatment 
Programs (Methadone, Buprenorphine)
• Provision of safe living environment
• Consistent Prenatal care institution 
• Counselling about smoking cessation (tobacco as well as 
marijuana)
• Prenatal consultation with the Pediatric/Neonatal team 
make families aware of potential for NAS and its 
management
• Familial awareness of their responsibilities and role in 
caring of their baby
Jones et al. Methadone and Buprenorphine for Management of opioid dependence  in pregnancy. Drugs. 2012 Jones et al. 
Neonatal Abstinence Syndrome after Methadone or Buprenorphine exposure. NEJM 2010
ACOG: Committee Opinion 2012. Opioid Abuse, Dependence and Addiction in Pregnancy
Postnatal Management
• Guidelines for monitoring
• Non-Pharmacological
• Pharmacological
Non-Pharmacological Management
• Initial management for all infants with NAS should 
be supportive care
– Immediate skin to skin care post-partum
– Providing non-nutritive sucking - pacifiers
– Swaddling
– Reduction in stimuli - light, noise
– Maintaining calm, quiet environment
– Small, frequent feedings with hypercaloric breast milk 
and/or formula to meet the calorie requirement
– Breastfeeding strongly recommended if mother is in 
stable MAT programs
Pharmacological Management
• If supportive care fails then the next level of care is 
pharmacotherapy
• The goal of pharmacotherapy is to
- Ameliorate the discomfort from withdrawal
- Promote growth
- Prevent seizures
• The choice of therapy should be tailored to the maternal 
medications in pregnancy
• Opioids are the main stay for treatment
• Adjunctive medications help shorten the overall treatment 
time with smaller doses of opioids needed to treat
• Most of these require in hospital treatment
Hudak M L et al. Pediatrics 2012;129:e540-e560
Post -Discharge
• Referral and follow-up with Early Intervention as high 
risk for neurocognitive and behavioral impairment
• Frequent follow-up 
- to optimize growth and nutrition
- to wean off medications if discharged home on them
(Methadone, Phenobarbital)
- to provide support to families as they transition from
hospital to home environment
Bandstra et al, J Addict Ds 2010
McMurray et al , Front Psychol 2013
Pre- conception
1. Education starting at  the 
school level 
2. Awareness and acceptance in 
community
3. Resources availability in 
community
Prenatal
1. Establishing early prenatal 
care 
2. MAT referrals 
3. Consistent care providers
4. Support programs like 
EMPOWER, Moms Do Care, 
Peer Support
5. Prenatal consult and 
education
6. Parental readiness and role 
assignments
Postnatal
1. Initiation of Skin to skin care, 
breastfeeding
2. Rooming-in care
3. Protocols for monitoring and 
treatment
4. Parents as primary care giver 
models
5. Staff education and Buy-in
6. Social support to navigate 
legal issues
Post-Discharge
1. Early Intervention referral 
and initiation
2. Continued maternal and 
infant medical follow-ups
3. Continued community 
resources availability
4. Continued peer support
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